Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARE: Plasmalyte vs Ringer Lactate in Severe Burn Resuscitation
NCT03118362Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of plasmalyte in burn injury, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Base deficit at 24 hours. Started Aug 2017; status: completed.
02
Drugs
plasmalyte
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT03118362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03118362.